Key facts
- This page summarizes Christopher M. Gallagher's Form 4 filing for SOC Telemed, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Apr 2022, 16:18.
Christopher M. Gallagher - 06 Apr 2022 Form 4 Insider Report for SOC Telemed, Inc.
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- N/A
- Reported as of
- 06 Apr 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2022, 16:18:38 UTC
- Prior SEC filing
- 22 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eunice Kim, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher M. Gallagher filed Form 4 for SOC Telemed, Inc. on 07 Apr 2022.
Change
- Previous filing in this sequence was filed on 22 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLMD
transaction
Class A Common Stock
Other
- Transaction value
- Shares
- -3,316,679
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Apr 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
TLMD
transaction
Class A Common Stock
Other
- Transaction value
- Shares
- -401,243
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 Apr 2022
- Ownership
- See footnote
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Christopher M. Gallagher is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
On April 6, 2022, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 2, 2022, by and among SOC Telemed, Inc. (the "Issuer"), Spark Parent, Inc. ("Parent") and Spark Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent, each share of the Issuer's Class A Common Stock (other than certain excluded shares) outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and automatically converted into the right to receive an amount in cash equal to $3.00 (the "Merger Consideration"), without any interest thereon and subject to any applicable withholding taxes.
Footnote F2
Excludes 1,080,000 restricted stock units (each, an "RSU"), each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock. Pursuant to the Merger Agreement, each RSU (other than those held by a non-employee director of the Issuer) that was not vested and outstanding as of immediately prior to the Effective Time was, automatically and without any required action on the part of the holder thereof, canceled and will be replaced with a new award to be issued by Parent or one of its affiliates following the Effective Time.
Footnote F3
Pursuant to agreements between an indirect parent entity of Parent and each of the Reporting Person and the Children's Trust (as defined below), the reported number of shares of Class A Common Stock were all rolled over into an investment in the indirect parent entity of Parent for an aggregate amount equal to the reported number of shares of Class A Common Stock multiplied by the per-share value of the Merger Consideration.
Footnote F4
Held in the name of Christopher Michael Gallagher and Katherine Ann Gallagher as Trustees of Gallagher 2020 Children's Trust (the "Children's Trust").